P3 Health Partners Inc. (PIII) Form 8-K — May 26, 2026
P3 Health Partners Inc. announced that it has regained compliance with Nasdaq continued listing requirements following a review by the exchange staff. This resolves a prior deficiency notice issued in November 2025 regarding stockholders' equity, market value, and net income standards. The company received a letter from Nasdaq on May 20, 2026, confirming compliance with Listing Rule 5550(b)(2) based on a previous Form 8-K filed on May 15, 2026.
Key figures
- Compliance rule
- Nasdaq Listing Rule 5550(b)(2)
Price after filing
1 day: +22.6%7 days: -1.5%30 days: -14.2%
Close on the filing date to close N calendar days later (from $12.99). Historical, not a forecast.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.